⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BTAI News
BioXcel Therapeutics, Inc. Common Stock
China-US Dual Filing Success: Porton Advanced's End-to-End Bacterial Vector CDMO Solution Accelerates NMPA Approval of Salvectors' Innovative Oncolytic Bacteria Therapy
prnewswire.com
BTAI
BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual Meeting
globenewswire.com
BTAI
BioAge Labs to Present at Upcoming Investor Conferences
globenewswire.com
BIOA
BTAI
Form 8-K
sec.gov
BTAI
BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
globenewswire.com
BTAI
Prevent Blindness Declares May as Third Annual Inherited Retinal Disease and Genetic Testing Month, Offering Resources to Public and Healthcare Allies, to Help Save Sight
prnewswire.com
BTAI
ALKS
BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease
globenewswire.com
BTAI
Form 8-K
sec.gov
BTAI
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
globenewswire.com
BTAI
Did BioXcel Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
BTAI